Us Congress 2025-2026 Regular Session

Us Congress House Bill HR305 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	IV
2	2	119THCONGRESS
3	3	1
4	4	STSESSION H. RES. 305
5	5	Expressing support for the designation of the fourth Wednesday of February
6	6	as ‘‘Hypertrophic Cardiomyopathy Awareness Day’’.
7	7	IN THE HOUSE OF REPRESENTATIVES
8	8	APRIL8, 2025
9	9	Mr. L
10	10	AHOODsubmitted the following resolution; which was referred to the
11	11	Committee on Energy and Commerce
12	12	RESOLUTION
13	13	Expressing support for the designation of the fourth Wednes-
14	14	day of February as ‘‘Hypertrophic Cardiomyopathy
15	15	Awareness Day’’.
16	16	Whereas hypertrophic cardiomyopathy (‘‘HCM’’) is a chronic
17	17	cardiac disease involving thickening of the heart muscle
18	18	and can potentially lead to debilitating symptoms and se-
19	19	rious complications including heart failure, atrial fibrilla-
20	20	tion, stroke, and in rare cases sudden cardiac death;
21	21	Whereas HCM is the most common inheritable heart disease
22	22	and can affect anyone regardless of age, gender, or eth-
23	23	nicity with a reported prevalence ranging from 1 in 200
24	24	to 1 in 500 in the general population;
25	25	Whereas an estimated 700,000 to 1,650,000 people in the
26	26	United States have HCM, yet 85 percent of them may
27	27	remain undiagnosed;
28	28	VerDate Sep 11 2014 23:59 Apr 08, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR305.IH HR305
29	29	ssavage on LAPJG3WLY3PROD with BILLS 2
30	30	•HRES 305 IH
31	31	Whereas HCM shares symptoms with other common cardio-
32	32	vascular and pulmonary diseases, such as shortness of
33	33	breath, chest pain, fatigue, palpitations, and fainting,
34	34	making it difficult to distinguish HCM from these other
35	35	diseases;
36	36	Whereas, when untreated, all-cause mortality risk is 3 to 4
37	37	times higher in patients with HCM than that of the gen-
38	38	eral population;
39	39	Whereas knowing one’s medical history and any signs and
40	40	symptoms of HCM is an important first step in receiving
41	41	an accurate diagnosis of HCM;
42	42	Whereas a health care provider must conduct thorough
43	43	screening with cardiac health questions to help identify a
44	44	risk of cardiac disorders, both genetic and congenital;
45	45	Whereas a health care provider may conduct several tests, in-
46	46	cluding an echocardiogram, a cardiac MRI, or genetic
47	47	testing to confirm a family history of HCM, and must ex-
48	48	amine the heart to diagnose HCM;
49	49	Whereas, following a diagnosis of HCM, it is important for
50	50	patients to work with their health care provider to learn
51	51	more about their disease and understand different man-
52	52	agement options, including prescription medicines and
53	53	surgical treatment options that may help; and
54	54	Whereas ‘‘Hypertrophic Cardiomyopathy Awareness Day’’ is
55	55	expected to be observed in the United States for years to
56	56	come, providing hope and information for patients, care-
57	57	givers, and families around the country: Now, therefore,
58	58	be it
59	59	Resolved, That the House of Representatives— 1
60	60	VerDate Sep 11 2014 23:59 Apr 08, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\HR305.IH HR305
61	61	ssavage on LAPJG3WLY3PROD with BILLS 3
62	62	•HRES 305 IH
63	63	(1) supports the designation of ‘‘Hypertrophic 1
64	64	Cardiomyopathy Awareness Day’’; 2
65	65	(2) acknowledges the critical importance of hy-3
66	66	pertrophic cardiomyopathy awareness to improve 4
67	67	cardiovascular health; and 5
68	68	(3) recognizes the need to raise public aware-6
69	69	ness of the consequences of undiagnosed and un-7
70	70	treated hypertrophic cardiomyopathy and urges all 8
71	71	Americans to seek appropriate care. 9
72	72	Æ
73	73	VerDate Sep 11 2014 23:59 Apr 08, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\HR305.IH HR305
74	74	ssavage on LAPJG3WLY3PROD with BILLS